Neumora Therapeutics, Inc. Common Stock
NMRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$244 | -$236 | -$131 | -$237 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$0 |
| Stock-Based Comp. | $40 | $17 | $8 | $4 |
| Change in WC | $23 | -$9 | -$7 | -$1 |
| Other Non-Cash | -$2 | $64 | $14 | $158 |
| Operating Cash Flow | -$183 | -$163 | -$115 | -$75 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$1 | -$1 |
| Net Acquisitions | -$1 | $0 | $0 | $0 |
| Inv. Purchases | -$312 | -$109 | -$226 | $0 |
| Inv. Sales/Matur. | $242 | $178 | $72 | $0 |
| Other Inv. Act. | $0 | -$5 | -$13 | $0 |
| Investing Cash Flow | -$71 | $64 | -$168 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $14 | $233 | $0 | $1 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8 | -$1 | $116 | $293 |
| Financing Cash Flow | $22 | $232 | $116 | $294 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$232 | $133 | -$167 | $217 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $375 | $242 | $409 | $192 |
| End Cash | $143 | $375 | $242 | $409 |
| Free Cash Flow | -$183 | -$163 | -$115 | -$76 |